Pharmaceuticals Company

Wells Pharma

30%

Funding Goal $5,000,000
Funding Raised So Far $1,275,000
Funding Commitments $225,000
Funding Remaining $3,500,000
Funding Type Debt Financing
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview


FDA registered pharmaceutical manufacturer offering Senior Debt with 14% interest plus Warrants. Revenue is tripling due to a nationwide contract with a hospital purchasing organization, positioning the company to reach $30 million in revenue.

Read More
lock icon

Unlock Company Profile

Sign up now to unlock full company profiles and access financials, investor documents, and engage companies.

Business Summary


Company Age 3 years, 2 months
Employees 53
Sub-Industry Drug Manufacturer
Prior Year Revenue
Current Year Revenue
Next Year Revenue

Products/Services


Pharmaceutical Drugs

Wells Pharma Offers Ready To Use:

Pre-Filled Syringes/ I.V. Bags/ Pain Pumps/ Parental Pain Control (PCAs)

* 33,000 square foot facility
* 7,500 square feet of cleanroom space
* Nationwide licensure (47 States and Washington DC)
* Currently servicing over 200 Hospitals and growing
* Robust product portfolio including 58 SKUs with 42 SKUs in development
* State of the Art Automation
* Strong sales pipeline
* Top quality, laboratory tested products
* Experienced and Networked Senior Leadership Team

Wells Pharma's products are utilized in virtually all departments of the hospital including, but not limited to; Anesthesiology, O.R., Emergency Room, Cardiology, Labor/Delivery, and Specialty.

Management


Tony Schwartz
Chief Executive Officer
Tony Schwartz

Mr. Schwartz has an extensive career and experience in the pharmaceutical industry spanning 25 years with such companies as J&J, Abbott Labs, Elan Pharma, and The Medicines Company. Since 2002, Mr. Schwartz has served the hospital segment of the business and has made significant contributions to drive revenues and improve the "bottom line" in all of his roles. Mr. Schwartz also spent two years of his career with ROi, a Group Purchasing Organization (GPO) serving as the General Manager and Executive Director of the 503B Facilities and Contracts. He has built and nurtured many relationships with hospital systems and within the pharmaceutical industry. His knowledge and expertise has been evident here at Wells and he continues to drive the business initiatives of the company and bring value to shareholders.

Andy Corbin
Chief Financial Officer
Andy Corbin

Andy is an accomplished executive leader in operations, finance, and technology-driven systems with more than 20 years of experience in the healthcare, digital healthcare, and pharmaceutical compounding facilities. He joins Wells Pharma of Houston, LLC. as CFO. Andy has held several C-Level positions with Sage Software Healthcare Division, StayWell Health Management, LifeLock, and most notably as WebMD's Corporate CFO and CEO of WebMD Practice Services Software Division. Most recently Andy was President and CFO at a 503B Outsourcing Facility where he opened and operated a built-for-purpose 42,000 square-foot manufacturing plant. Andy’s wealth of experience makes him a great addition to the Wells Pharma Team.

Theaquiata Mitchell
Vice President Quality Assurance
Theaquiata Mitchell

Theaquiata Mitchell has nearly 20 years of experience in quality. As a Quality Assurance professional, she joined Wells Pharma of Houston, LLC with a vast array of skills in Regulatory Compliance for Pharmaceutical, Medical Device, and Ambient and Frozen Tissue for Implants, as well as Validation and Environmental Safety and Health experience. Additionally, Mrs. Mitchell has experience in the 503B market, having worked for one of the leading companies at the time (PharMEDium). Mrs. Mitchell brings her knowledge and skills to Wells and has had an excellent track record in meeting and exceeding the regulatory environment of the 503B market.

Sofia Muma
Managing Director Physician/Medical Officer
Sofia Muma

Sophia is an accomplished leader in pharmaceutical, operational, and business development providing a blend of pharmacy and business development with more than 20 years of experience in pharmacy operations and pharmaceutical compounding facilities. She joins Wells Pharma of Houston, LLC. as a Pharmacist in Charge (PIC). Sophia has held several leadership positions with Southside Infusion Pharmacy and Healix Infusion Pharmacy as a PIC, and most notably as part of the management team at PharMedium 503B Outsourcing Facility, a division of Amerisource Bergen in Houston, TX . Most recently Sophia was a PIC at Southside infusion where she managed and operated the cleanroom. Sophia's wealth of experience in clinical, quality, and business development makes her a great addition to the Wells Pharma Team.

Investors/Lenders


Family Wealth Office
Affiliates of National Financial Companies (nfcllc.com)

National Financial Copanies is a Merchant Banking Firm established in 1991 to pursue high growth opportunities . Partners and associated parties have invested in and successfully exited over 30 companies in healthcare, pharmacy, financial services, manufacturing and consumer products

Amount
Investment Type
Investment Round
Investment Date

30%

Funding Goal $5,000,000
Funding Raised So Far $1,275,000
Funding Commitments $225,000
Funding Remaining $3,500,000
Funding Type Debt Financing
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Documents


Contact


Wells Pharma

Houston, TX 77054, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).